Does BEVACIZUMAB Cause Myelosuppression? 1,744 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,744 reports of Myelosuppression have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 2.2% of all adverse event reports for BEVACIZUMAB.
1,744
Reports of Myelosuppression with BEVACIZUMAB
2.2%
of all BEVACIZUMAB reports
48
Deaths
597
Hospitalizations
How Dangerous Is Myelosuppression From BEVACIZUMAB?
Of the 1,744 reports, 48 (2.8%) resulted in death, 597 (34.2%) required hospitalization, and 112 (6.4%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 1,744 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
SODIUM (1,696)
METHOTREXATE (1,523)
Which BEVACIZUMAB Alternatives Have Lower Myelosuppression Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ